
Boston Harbor Angels
Description
Boston Harbor Angels (BHA) is a prominent angel investment group based in Boston, Massachusetts, comprising a network of experienced business leaders, entrepreneurs, and investors. The group focuses on providing early-stage capital to high-growth companies, leveraging the collective expertise and resources of its members. BHA aims to identify innovative ventures with significant market potential and strong management teams, offering not just financial backing but also strategic guidance and mentorship.
The group's investment thesis centers on companies poised for rapid expansion and possessing a clear path to a successful exit. While sector-agnostic to some extent, Boston Harbor Angels has shown a particular interest in technology-driven sectors, including healthcare, software, and biotechnology. They meticulously evaluate prospective portfolio companies based on factors such as market opportunity, competitive advantage, scalability, and the strength of the founding team.
Boston Harbor Angels typically invests in companies seeking seed or Series A funding. Their standard investment per company ranges from $250,000 to $1,500,000, often participating in syndicated rounds with other angel groups or venture capital firms. This approach allows them to pool capital and expertise, providing more substantial support to their portfolio companies while diversifying risk for individual members.
Founded in 2004, Boston Harbor Angels has been an active participant in the entrepreneurial ecosystem for nearly two decades. Over this period, BHA has built a diverse portfolio of companies, contributing significantly to the growth of early-stage ventures in New England and beyond. Their commitment extends beyond capital, as members frequently engage with portfolio companies, offering invaluable operational experience and industry connections to help accelerate their development and achieve key milestones.
Investor Profile
Boston Harbor Angels has backed more than 126 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 7% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Angel, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada, Israel.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Typical check size: $250K – $1.5M.
Stage Focus
- Angel (57%)
- Seed (19%)
- Series A (9%)
- Series B (6%)
- Series Unknown (6%)
- Convertible Note (1%)
- Pre Seed (1%)
- Series D (1%)
- Series C (1%)
Country Focus
- United States (96%)
- Canada (2%)
- Israel (1%)
- India (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical Device
- Medical
- Manufacturing
- Software
- Pharmaceutical
- Information Technology
- E-commerce
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.